Medical Devices

As RenovoRx preps its Q2 update, it's proving its mettle on two fronts: impressive sales of its RenovoCath device and a critical milestone in its pancreatic cancer trial.

A new class of disposable devices makes a common surgery four times faster and five times less bloody. So why is this Asia-led innovation invisible to US regulators?

Solid Q2 earnings are just the start. Photocure is moving beyond its core imaging tech with key acquisitions and AI partnerships, building a full-spectrum platform.

With strong Q2 results and strategic acquisitions, Mirion is capitalizing on the global push for nuclear energy while reaffirming a confident 2026 forecast.

As Ceribell preps for a key investor conference, we analyze its AI-powered EEG platform, its rapid clinical adoption, and its strategy for market dominance.

As dental giant Envista preps its September investor summit, it must prove its operational engine and digital pivot can convert recent financial wins into lasting value.

eXeX's new CXO has a background in the NFL and distilling. His appointment signals a major shift in MedTech, where provider support is now key to patient care.

With over 40 years of financial leadership, Dave Ascani joins Leap Distributors to scale operations and navigate the complex MedTech distribution landscape.

Facing delisting and declining revenue, STRATA taps a commercial expert to turn reimbursement codes into a growth story. It's a high-stakes MedTech pivot.

A new partnership between B-Secur and CSEM combines ECG and PPG tech, promising to turn consumer wearables into powerful, clinically-validated heart monitors.

A landmark FDA approval allows Walter Reed to 3D-print cranial implants on-site, a strategic shift in military medicine powered by 3D Systems' expertise.

A 57% stock plunge and a securities fraud lawsuit against Embecta Corp. reveal the high stakes of corporate guidance and the new era of accountability.

With revenues falling and losses mounting, Vitalist Inc. is making a bold play. Can a new Reebok smartwatch and a pivot to medical AI save the company?

With labs facing staff shortages and rising demand, SCIEX's new software and hardware promise to speed up critical test results from sample to answer.

A breakthrough BCI not only restores movement and sensation but promotes lasting change. Joyce Watson analyzes how Neuvotion is turning science into a business.

Fairtility's expanded AI partnership with First Fertility isn't just a tech deployment. It's a key signal that the battle for dominance in the fertility market is shifting to a new trifecta: operational scale, data-driven precision, and a radically transparent patient experience.

A new $6.3M funding round for Dopl Technologies isn't just about money. It's about a future where telerobotics could bring critical ultrasound exams to millions.

New trial data shows an incision-free therapy preserves patient quality of life, challenging the long-held dominance of robotic surgery in prostate cancer.

A Gold Stevie Award for hear.com isn't just a trophy; it's a market signal for how tele-audiology and AI are building a durable future for hearing care.

A new Centre of Excellence in India aims to tackle the critical global shortage of retina specialists, leveraging a hybrid training model to prevent blindness.